View Older Stories

Mar 2, 2026 01:09PM United Therapeutics Corp. (UTHR) PT Raised to $615 at Leerink Partners

Mar 2, 2026 12:33PM H.C. Wainwrigh on United Therapeutics Corp. (UTHR): 'We believe ralinepag is a win mechanistically and clinically'

Mar 2, 2026 06:31AM United Therapeutics ralinepag shows 55% risk reduction in PAH study

Feb 26, 2026 12:23PM United Therapeutics Corp. (UTHR) PT Raised to $600 at H.C. Wainwright

Feb 25, 2026 04:32PM United Therapeutics Corp. (UTHR) PT Raised to $575 at TD Cowen

Feb 25, 2026 03:30PM United Therapeutics Corp. (UTHR) PT Raised to $569 at BofA Securities

Feb 25, 2026 06:30AM United Therapeutics (UTHR) Tops Q4 EPS by 60c

Feb 17, 2026 10:49AM UBS Reiterates Buy Rating on United Therapeutics Corp. (UTHR)

Jan 2, 2026 10:35AM Increasing unusual option volume: PSQ UTHR OTLK IONS PTEN FEZ PEPG SLS LEG WSM UA BRKR EU ZSL ARMN PENG

Dec 19, 2025 09:06AM TD Cowen on Biotechnology: '10+ Potential "Thome Run" Catalysts To Watch In 2026'

Nov 19, 2025 04:24AM Jefferies Reiterates Buy Rating on United Therapeutics Corp. (UTHR)

Oct 29, 2025 03:01PM BTIG on United Therapeutics Corp. (UTHR): 'we would love to see data post-launch on the cadence of adoption, both in PAH and PH-ILD'

Oct 29, 2025 02:07PM United Therapeutics Corp. (UTHR) PT Raised to $575 at Jefferies

Oct 29, 2025 01:43PM United Therapeutics Corp. (UTHR) PT Raised to $525 at TD Cowen

Oct 29, 2025 12:14PM United Therapeutics (UTHR) PT Raised to $447 at Morgan Stanley

Oct 29, 2025 06:31AM United Therapeutics (UTHR) Misses Q3 EPS by 16c

Oct 2, 2025 09:28AM TD Cowen on United Therapeutics Corp. (UTHR): 'Survey Highlight Significant IPF Tyvaso Opportunity'

Oct 2, 2025 04:12AM Jefferies on United Therapeutics Corp. (UTHR): 'we don't think the new order/ responses change our view on trial outcomes'

Oct 1, 2025 08:09AM UBS Reiterates Buy Rating on United Therapeutics Corp. (UTHR)

Sep 29, 2025 06:58AM H.C. Wainwright Reiterates Buy Rating on United Therapeutics Corp. (UTHR)

Sep 29, 2025 05:56AM United Therapeutics Corp. (UTHR) PT Raised to $580 at UBS

Sep 29, 2025 04:14AM TD Cowen Reiterates Buy Rating on United Therapeutics Corp. (UTHR)

Sep 26, 2025 02:38AM RBC Capital Starts United Therapeutics Corp. (UTHR) at Outperform

Sep 11, 2025 09:06AM United Therapeutics Corp. (UTHR) Stock Can 'Continue to Grind Higher' — UBS

Sep 10, 2025 06:42AM United Therapeutics Corp. (UTHR) PT Raised to $525 at Cantor Fitzgerald

Sep 5, 2025 06:33AM United Therapeutics Corp. (UTHR) PT Raised to $500 at H.C. Wainwright

Sep 5, 2025 06:13AM United Therapeutics Corp. (UTHR) PT Raised to $575 at Oppenheimer

Sep 4, 2025 06:01AM United Therapeutics Corp. (UTHR) PT Raised to $560 at UBS

Sep 2, 2025 03:43PM United Therapeutics (UTHR) call put ratio 1 call to 6.3 puts with a focus on October and November puts as share price up 33%

Sep 2, 2025 10:42AM United Therapeutics Corp. (UTHR) PT Raised to $564 at Jefferies

Sep 2, 2025 07:00AM United Therapeutics' Tyvaso meets primary endpoint in IPF study

Aug 27, 2025 08:06AM MannKind expands United Therapeutics partnership for second inhaled therapy

Aug 19, 2025 07:44AM UBS Reiterates Buy Rating on United Therapeutics Corp. (UTHR)

Aug 14, 2025 07:22AM Cantor Fitzgerald Reiterates Overweight Rating on United Therapeutics Corp. (UTHR)

Aug 13, 2025 05:23AM United Therapeutics Corp. (UTHR) PT Raised to $415 at UBS

Jul 31, 2025 06:42AM United Therapeutics Corp. (UTHR) PT Lowered to $400 at H.C. Wainwright

Jul 30, 2025 06:31AM United Therapeutics (UTHR) Misses Q2 EPS by 94c

Jun 30, 2025 07:56AM United Therapeutics Corp. (UTHR) PT Lowered to $385 at UBS

Jun 23, 2025 07:05AM United Therapeutics (UTHR) Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial Hypertension

Jun 10, 2025 08:45AM Leerink on Insmed (INSM) as Shares Surge 26pct: 'we continue to view INSM as a core Rare Disease/blockbuster platform'

Jun 4, 2025 06:23AM Leerink Partners Reiterates Outperform Rating on United Therapeutics Corp. (UTHR)

Jun 2, 2025 01:38PM Raymond James on Liquidia Technologies (LQDA): 'we maintain our positive outlook for the simultaneous Yutrepia launches in PAH and PH-ILD'

May 7, 2025 09:45AM TD Cowen: 'We Continue to See United Therapeutics Corp. (UTHR) Shares as Undervalued'

May 1, 2025 05:17AM United Therapeutics Corp. (UTHR) PT Raised to $321 at BofA Securities

Apr 30, 2025 06:31AM United Therapeutics (UTHR) Tops Q1 EPS by 10c

Apr 25, 2025 07:04AM Wells Fargo Downgrades United Therapeutics Corp. (UTHR) to Equal Weight

Apr 21, 2025 08:25AM BofA Securities Upgrades United Therapeutics Corp. (UTHR) to Neutral

Feb 27, 2025 04:56AM United Therapeutics Corp. (UTHR) PT Lowered to $293 at Goldman Sachs

Feb 26, 2025 06:33AM United Therapeutics (UTHR) Misses Q4 EPS by 49c

Feb 3, 2025 07:00AM United Therapeutics (UTHR) Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial

View Older Stories